KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
Conclusions
Exogenous hepatic KLF2 upregulation improves liver fibrosis, endothelial dysfunction and portal hypertension in cirrhosis.
Source: Gut - Category: Gastroenterology Authors: Marrone, G., Maeso-Diaz, R., Garcia-Cardena, G., Abraldes, J. G., Garcia-Pagan, J. C., Bosch, J., Gracia-Sancho, J. Tags: Cirrhosis Hepatology Source Type: research
More News: Adenoviruses | Cholesterol | Cirrhosis | Gastroenterology | Hypertension | Liver | Simvastatin | Statin Therapy | Urology & Nephrology | Zocor